john pimanda
john pimanda
Verified email at
Cited by
Cited by
Combinatorial transcriptional control in blood stem/progenitor cells: genome-wide analysis of ten major transcriptional regulators
NK Wilson, SD Foster, X Wang, K Knezevic, J Schütte, P Kaimakis, ...
Cell stem cell 7 (4), 532-544, 2010
Adult cardiac-resident MSC-like stem cells with a proepicardial origin
JJH Chong, V Chandrakanthan, M Xaymardan, NS Asli, J Li, I Ahmed, ...
Cell stem cell 9 (6), 527-540, 2011
Analysing high-throughput sequencing data in Python with HTSeq 2.0
GH Putri, S Anders, PT Pyl, JE Pimanda, F Zanini
Bioinformatics 38 (10), 2943-2945, 2022
Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer
YS Ju, LB Alexandrov, M Gerstung, I Martincorena, S Nik-Zainal, ...
elife 3, e02935, 2014
Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo
PS Woll, U Kjällquist, O Chowdhury, H Doolittle, DC Wedge, S Thongjuea, ...
Cancer cell 25 (6), 794-808, 2014
Gata2, Fli1, and Scl form a recursively wired gene-regulatory circuit during early hematopoietic development
JE Pimanda, K Ottersbach, K Knezevic, S Kinston, WYI Chan, NK Wilson, ...
Proceedings of the National Academy of Sciences 104 (45), 17692-17697, 2007
A menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia
AV Krivtsov, K Evans, JY Gadrey, BK Eschle, C Hatton, HJ Uckelmann, ...
Cancer cell 36 (6), 660-673. e11, 2019
Differential DNA repair underlies mutation hotspots at active promoters in cancer genomes
D Perera, RC Poulos, A Shah, D Beck, JE Pimanda, JWH Wong
Nature 532 (7598), 259-263, 2016
Cancerous inhibitor of protein phosphatase 2A, an emerging human oncoprotein and a potential cancer therapy target
A Khanna, JE Pimanda, J Westermarck
Cancer research 73 (22), 6548-6553, 2013
The non-coding RNA landscape of human hematopoiesis and leukemia
A Schwarzer, S Emmrich, F Schmidt, D Beck, M Ng, C Reimer, FF Adams, ...
Nature communications 8 (1), 1-17, 2017
Genome-wide analysis of transcriptional regulators in human HSPCs reveals a densely interconnected network of coding and noncoding genes
D Beck, JAI Thoms, D Perera, J Schütte, A Unnikrishnan, K Knezevic, ...
Blood, The Journal of the American Society of Hematology 122 (14), e12-e22, 2013
The proto-oncogene ERG in megakaryoblastic leukemias
L Rainis, T Toki, JE Pimanda, E Rosenthal, K Machol, S Strehl, ...
Cancer research 65 (17), 7596-7602, 2005
Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition
PS Bachmann, RG Piazza, ME Janes, NC Wong, C Davies, A Mogavero, ...
Blood, The Journal of the American Society of Hematology 116 (16), 3013-3022, 2010
Opposing regulation of BIM and BCL2 controls glucocorticoid-induced apoptosis of pediatric acute lymphoblastic leukemia cells
D Jing, VA Bhadri, D Beck, JAI Thoms, NA Yakob, JWH Wong, K Knezevic, ...
Blood, The Journal of the American Society of Hematology 125 (2), 273-283, 2015
The SCL transcriptional network and BMP signaling pathway interact to regulate RUNX1 activity
JE Pimanda, IJ Donaldson, MFTR De Bruijn, S Kinston, K Knezevic, ...
Proceedings of the National Academy of Sciences 104 (3), 840-845, 2007
ERG dependence distinguishes developmental control of hematopoietic stem cell maintenance from hematopoietic specification
S Taoudi, T Bee, A Hilton, K Knezevic, J Scott, TA Willson, C Collin, ...
Genes & development 25 (3), 251-262, 2011
Whole-transcriptome analysis of endothelial to hematopoietic stem cell transition reveals a requirement for Gpr56 in HSC generation
P Solaimani Kartalaei, T Yamada-Inagawa, CS Vink, E de Pater, ...
Journal of Experimental Medicine 212 (1), 93-106, 2015
Integrative genomics identifies the molecular basis of resistance to azacitidine therapy in myelodysplastic syndromes
A Unnikrishnan, E Papaemmanuil, D Beck, NP Deshpande, A Verma, ...
Cell reports 20 (3), 572-585, 2017
ERG promotes T-acute lymphoblastic leukemia and is transcriptionally regulated in leukemic cells by a stem cell enhancer
JAI Thoms, Y Birger, S Foster, K Knezevic, Y Kirschenbaum, ...
Blood, The Journal of the American Society of Hematology 117 (26), 7079-7089, 2011
Congenital thrombotic thrombocytopenic purpura in association with a mutation in the second CUB domain of ADAMTS13
JE Pimanda, A Maekawa, T Wind, J Paxton, CN Chesterman, PJ Hogg
Blood 103 (2), 627-629, 2004
The system can't perform the operation now. Try again later.
Articles 1–20